跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Estrogen/Progesterone
首页
药物
Estrogen/Progesterone
Estrogen/Progesterone
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES
EP 3936133 A1
申请人: THERAPEUTICSMD INC
优先权: 2011
EP
US
WO
27 件公开
EP 4309646 A1
申请人: THERAPEUTICSMD INC
优先权: 2012
EP
US
17 件公开
Dipeptide derivatives
US 6924280 B2
申请人: PFIZER
优先权: 2001
US
14 件公开
Cyclothiocarbamate derivatives as progesterone receptor modulators
US 7081457 B2
申请人: LIGAND PHARM INC
优先权: 2002
US
10 件公开
BREAST CANCER THERAPY BASED ON HORMONE RECEPTOR STATUS WITH NANOPARTICLES COMPRISING TAXANE
EP 3470071 A1
申请人: ABRAXIS BIOSCIENCE LLC
优先权: 2006
CN
EP
US
9 件公开
TARGETED MEASURE OF TRANSCRIPTIONAL ACTIVITY RELATED TO HORMONE RECEPTORS
EP 4029950 A1
申请人: UNIV TEXAS
优先权: 2016
EP
US
WO
8 件公开
Progesterone antagonists such as CDB-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer, etc
US 8426394 B2
申请人: PODOLSKI JOSEPH S
优先权: 2008
CN
US
6 件公开
COMPOSITIONS FOR SUPPRESSING ENDOMETRIAL PROLIFERATION
EP 3693376 A1
申请人: ALLERGAN PHARMACEUTICALS INT LTD
优先权: 2006
EP
US
5 件公开
Hormonally up-regulated, neu-tumor-associated kinase
US 7119185 B2
申请人: UNIV PENNSYLVANIA
优先权: 2001
US
5 件公开
CHIMERIC POLYPEPTIDES AND METHODS OF ALTERING THEIR LOCALISATION IN THE CELL MEMBRANE
EP 3601330 C0
申请人: CELL DESIGN LABS INC
优先权: 2017
CN
EP
WO
4 件公开
ENCAPSULATED CELLS FOR HORMONE REPLACEMENT THERAPY
EP 3138571 A1
申请人: UNIV WAKE FOREST HEALTH SCIENCES
优先权: 2011
EP
US
4 件公开
US 10398739 B2
申请人: UNIV WAKE FOREST HEALTH SCIENCES
优先权: 2014
US
第 1 / 10 页
上一页
下一页
药物
反馈